These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
609 related articles for article (PubMed ID: 32979504)
21. Therapeutic Methods for Gut Microbiota Modification in Lipopolysaccharide-Associated Encephalopathy. Li S; Guo H; Xu X; Hua R; Zhao Q; Li J; Lv J; Li J Shock; 2021 Nov; 56(5):824-831. PubMed ID: 33595259 [TBL] [Abstract][Full Text] [Related]
22. Rebuilding the Gut Microbiota Ecosystem. Gagliardi A; Totino V; Cacciotti F; Iebba V; Neroni B; Bonfiglio G; Trancassini M; Passariello C; Pantanella F; Schippa S Int J Environ Res Public Health; 2018 Aug; 15(8):. PubMed ID: 30087270 [TBL] [Abstract][Full Text] [Related]
23. Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease. Suk KT; Kim DJ Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):193-204. PubMed ID: 30791767 [TBL] [Abstract][Full Text] [Related]
24. Effects and Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota: A Narrative Review. Li HY; Zhou DD; Gan RY; Huang SY; Zhao CN; Shang A; Xu XY; Li HB Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579087 [TBL] [Abstract][Full Text] [Related]
25. Targeting the microbiome to improve human health with the approach of personalized medicine: Latest aspects and current updates. Shukla V; Singh S; Verma S; Verma S; Rizvi AA; Abbas M Clin Nutr ESPEN; 2024 Oct; 63():813-820. PubMed ID: 39178987 [TBL] [Abstract][Full Text] [Related]
26. Dysfunction of the Microbiota-Gut-Brain Axis in Neurodegenerative Disease: The Promise of Therapeutic Modulation With Prebiotics, Medicinal Herbs, Probiotics, and Synbiotics. Peterson CT J Evid Based Integr Med; 2020; 25():2515690X20957225. PubMed ID: 33092396 [TBL] [Abstract][Full Text] [Related]
27. Human Gut Microbiome: A New Frontier in Cancer Diagnostics & Therapeutics. Rani V; Singhal S; Sharma K; Vaid R; Aggarwal K; Bhadana R; Agarwal R; Atale N Curr Pharm Des; 2021; 27(45):4578-4592. PubMed ID: 34620056 [TBL] [Abstract][Full Text] [Related]
28. Gut microbiome modulation by probiotics, prebiotics, synbiotics and postbiotics: a novel strategy in food allergy prevention and treatment. Shi J; Wang Y; Cheng L; Wang J; Raghavan V Crit Rev Food Sci Nutr; 2024; 64(17):5984-6000. PubMed ID: 36576159 [TBL] [Abstract][Full Text] [Related]
29. Human gut microbiota/microbiome in health and diseases: a review. Gomaa EZ Antonie Van Leeuwenhoek; 2020 Dec; 113(12):2019-2040. PubMed ID: 33136284 [TBL] [Abstract][Full Text] [Related]
30. Gut microbiome in healthy aging versus those associated with frailty. Lim MY; Nam YD Gut Microbes; 2023 Dec; 15(2):2278225. PubMed ID: 37968837 [TBL] [Abstract][Full Text] [Related]
31. Microbiota dysbiosis and myasthenia gravis: Do all roads lead to Rome? Kapoor B; Gulati M; Gupta R; Singla RK Autoimmun Rev; 2023 May; 22(5):103313. PubMed ID: 36918089 [TBL] [Abstract][Full Text] [Related]
32. Emerging Evidence on the Use of Probiotics and Prebiotics to Improve the Gut Microbiota of Older Adults with Frailty Syndrome: A Narrative Review. Sánchez Y Sánchez de la Barquera B; Martínez Carrillo BE; Aguirre Garrido JF; Martínez Méndez R; Benítez Arciniega AD; Valdés Ramos R; Soto Piña AE J Nutr Health Aging; 2022; 26(10):926-935. PubMed ID: 36259581 [TBL] [Abstract][Full Text] [Related]
33. Pancreatic Cancer and Gut Microbiome-Related Aspects: A Comprehensive Review and Dietary Recommendations. Sobocki BK; Kaźmierczak-Siedlecka K; Folwarski M; Hawryłkowicz V; Makarewicz W; Stachowska E Nutrients; 2021 Dec; 13(12):. PubMed ID: 34959977 [TBL] [Abstract][Full Text] [Related]
34. Gut Microbiota and Complications of Type-2 Diabetes. Iatcu CO; Steen A; Covasa M Nutrients; 2021 Dec; 14(1):. PubMed ID: 35011044 [TBL] [Abstract][Full Text] [Related]
35. Modulating the gut microbiota by probiotics, prebiotics, postbiotics, and fecal microbiota transplantation: An emerging trend in cancer patient care. Ciernikova S; Sevcikova A; Drgona L; Mego M Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):188990. PubMed ID: 37742728 [TBL] [Abstract][Full Text] [Related]
36. Microbiota, Bacterial Carbonic Anhydrases, and Modulators of Their Activity: Links to Human Diseases? Amedei A; Capasso C; Nannini G; Supuran CT Mediators Inflamm; 2021; 2021():6926082. PubMed ID: 34803517 [TBL] [Abstract][Full Text] [Related]
37. Modulation of gut microbiome in nonalcoholic fatty liver disease: pro-, pre-, syn-, and antibiotics. Cho MS; Kim SY; Suk KT; Kim BY J Microbiol; 2018 Dec; 56(12):855-867. PubMed ID: 30377993 [TBL] [Abstract][Full Text] [Related]
38. Can manipulation of gut microbiota really be transformed into an intervention strategy for cardiovascular disease management? Mehmood K; Moin A; Hussain T; Rizvi SMD; Gowda DV; Shakil S; Kamal MA Folia Microbiol (Praha); 2021 Dec; 66(6):897-916. PubMed ID: 34699042 [TBL] [Abstract][Full Text] [Related]
39. Understanding the gut microbiota in cancer cachexia. Rocha IM; Fonseca DC; Torrinhas RSM; Waitzberg DL Curr Opin Clin Nutr Metab Care; 2023 Sep; 26(5):482-489. PubMed ID: 37389459 [TBL] [Abstract][Full Text] [Related]
40. A New Approach to Polycystic Ovary Syndrome: The Gut Microbiota. Yurtdaş G; Akdevelioğlu Y J Am Coll Nutr; 2020; 39(4):371-382. PubMed ID: 31513473 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]